These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 24831601)

  • 1. Lower phosphorylated glycogen synthase kinase-3B levels in platelets of patients with schizophrenia: increment by olanzapine treatment.
    Ferreira AS; Raposo NR; Sallet PC; Van de Bilt MT; Machado-Vieira R; Talib LL; Gattaz WF
    Eur Arch Psychiatry Clin Neurosci; 2015 Mar; 265(2):167-70. PubMed ID: 24831601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DRD2/AKT1 interaction on D2 c-AMP independent signaling, attentional processing, and response to olanzapine treatment in schizophrenia.
    Blasi G; Napolitano F; Ursini G; Taurisano P; Romano R; Caforio G; Fazio L; Gelao B; Di Giorgio A; Iacovelli L; Sinibaldi L; Popolizio T; Usiello A; Bertolino A
    Proc Natl Acad Sci U S A; 2011 Jan; 108(3):1158-63. PubMed ID: 21187413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effects of olanzapine and haloperidol on serum withdrawal-induced apoptosis in SH-SY5Y cells.
    Kim NR; Park SW; Lee JG; Kim YH
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):633-42. PubMed ID: 18055082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of olanzapine on brain-derived neurotrophic factor gene promoter activity in SH-SY5Y neuroblastoma cells.
    Lee JG; Cho HY; Park SW; Seo MK; Kim YH
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Aug; 34(6):1001-6. PubMed ID: 20546816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lithium increases platelet serine-9 phosphorylated GSK-3β levels in drug-free bipolar disorder during depressive episodes.
    de Sousa RT; Zanetti MV; Talib LL; Serpa MH; Chaim TM; Carvalho AF; Brunoni AR; Busatto GF; Gattaz WF; Machado-Vieira R
    J Psychiatr Res; 2015 Mar; 62():78-83. PubMed ID: 25691093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of antipsychotic drugs on BDNF, GSK-3β, and β-catenin expression in rats subjected to immobilization stress.
    Park SW; Phuong VT; Lee CH; Lee JG; Seo MK; Cho HY; Fang ZH; Lee BJ; Kim YH
    Neurosci Res; 2011 Dec; 71(4):335-40. PubMed ID: 21893111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Parameters of platelet serotonin system in patients with schizophrenia treated with olanzapine: a search for the serotonergic predictors of therapeutic efficacy].
    Brusov OS; Faktor MI; Zlobina GP; Dupin AM; Katasonov AB; Kartseva NK; Beniashvili AG; Zharkova NB; Rubashkina VV; Morozova MA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(3):27-34. PubMed ID: 15825226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Olanzapine inhibits glycogen synthase kinase-3beta: an investigation by docking simulation and experimental validation.
    Mohammad MK; Al-Masri IM; Taha MO; Al-Ghussein MA; Alkhatib HS; Najjar S; Bustanji Y
    Eur J Pharmacol; 2008 Apr; 584(1):185-91. PubMed ID: 18295757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Switching patients with stable schizophrenia or schizoaffective disorder from olanzapine to risperidone long-acting injectable.
    Rosa F; Schreiner A; Thomas P; Sherif T
    Clin Drug Investig; 2012 Apr; 32(4):267-79. PubMed ID: 22339430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of olanzapine treatment on platelet glutamine synthetase-like protein and glutamate dehydrogenase immunoreactivity in schizophrenia.
    Burbaeva GSh; Boksha IS; Tereshkina EB; Savushkina OK; Turishcheva MS; Starodubtseva LI; Brusov OS; Morozova MA
    World J Biol Psychiatry; 2006; 7(2):75-81. PubMed ID: 16684679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Olanzapine versus aripiprazole for the treatment of agitation in acutely ill patients with schizophrenia.
    Kinon BJ; Stauffer VL; Kollack-Walker S; Chen L; Sniadecki J
    J Clin Psychopharmacol; 2008 Dec; 28(6):601-7. PubMed ID: 19011427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcome and olanzapine plasma levels in acute schizophrenia.
    Mauri MC; Steinhilber CP; Marino R; Invernizzi E; Fiorentini A; Cerveri G; Baldi ML; Barale F
    Eur Psychiatry; 2005 Jan; 20(1):55-60. PubMed ID: 15642445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positive correlation between overexpression of phospho-BAD with phosphorylated Akt at serine 473 but not threonine 308 in colorectal carcinoma.
    Khor TO; Gul YA; Ithnin H; Seow HF
    Cancer Lett; 2004 Jul; 210(2):139-50. PubMed ID: 15183529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term sertraline treatment increases expression and decreases phosphorylation of glycogen synthase kinase-3B in platelets of patients with late-life major depression.
    Joaquim HP; Talib LL; Forlenza OV; Diniz BS; Gattaz WF
    J Psychiatr Res; 2012 Aug; 46(8):1053-8. PubMed ID: 22622071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term antipsychotic monotherapy for schizophrenia: disease burden and comparative outcomes for patients treated with olanzapine, quetiapine, risperidone, or haloperidol monotherapy in a pan-continental observational study.
    Dossenbach M; Pecenak J; Szulc A; Irimia V; Anders M; Logozar-Perkovic D; Peciukaitiene D; Kotler M; Smulevich AB; West TM; Lowry AJ; Treuer T
    J Clin Psychiatry; 2008 Dec; 69(12):1901-15. PubMed ID: 19012820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neural changes associated with appetite information processing in schizophrenic patients after 16 weeks of olanzapine treatment.
    Stip E; Lungu OV; Anselmo K; Letourneau G; Mendrek A; Stip B; Lipp O; Lalonde P; Bentaleb LA
    Transl Psychiatry; 2012 Jun; 2(6):e128. PubMed ID: 22714121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of olanzapine long-acting injection on levels of functioning among acutely ill patients with schizophrenia.
    Witte MM; Case MG; Schuh KJ; Ascher-Svanum H
    Curr Med Res Opin; 2012 Mar; 28(3):315-23. PubMed ID: 22236137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GSK-3beta regulation in skeletal muscles by adrenaline and insulin: evidence that PKA and PKB regulate different pools of GSK-3.
    Jensen J; Brennesvik EO; Lai YC; Shepherd PR
    Cell Signal; 2007 Jan; 19(1):204-10. PubMed ID: 16934435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sulpiride augmentation of olanzapine in the management of treatment-resistant chronic schizophrenia: evidence for improvement of mood symptomatology.
    Kotler M; Strous RD; Reznik I; Shwartz S; Weizman A; Spivak B
    Int Clin Psychopharmacol; 2004 Jan; 19(1):23-6. PubMed ID: 15101566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ultrastructural changes in platelets and their relationship with serotonin metabolism in patients with schizophrenia treated with olanzapine].
    Bonartsev PD; Rakhmanova VI; Bezrukov MV; Faktor MI; Brusov OS; Uranova NA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(2):42-6. PubMed ID: 24662344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.